UBS Genomic Medicine Summit
XiFin CEO Lâle White to Speak on Genomic Testing Panel
Join XiFin at the UBS Genomic Medicine Summit to engage with leading analysts and industry experts on critical issues and advancements affecting the industry. This intimate gathering hosts an array of speakers and thought leaders presenting on issues specific to genomic medicine, including the future of cancer screenings, the application of artificial intelligence (AI) to medicine, and the future of genetic testing. Be sure to join us in small group and one-on-one discussions during this industry networking event.
Regulation and Reimbursement in Genomic Testing
Lâle White
Executive Chair and CEO, XiFin, Inc.
Bruce Quinn, MD, PhD
Principal, Bruce Quinn Associates, LLC
Gabriel Bien-Willner, MD, PhD
Chief Medical Officer, Palmetto GBA
Session Information
Pulling from her extensive diagnostic and research experience, XiFin’s Executive Chair and CEO, Lâle White, will be a featured speaker on Wednesday, August 14, 2024, from 11:45 AM to 12:25 PM PT.
Learn the latest regulatory and reimbursement challenges in genomic testing as Lâle provides data-driven insights on the evolving landscape of laboratory management and the impact of recent genomic testing developments. She will be joined by fellow industry leaders Bruce Quinn, Principal at Bruce Quinn Associates LLC, and Gabriel Bien-Willner, Chief Medical Officer at Palmetto GBA to discuss a range of topics:
- Genomic Technologies: Innovations in liquid biopsy, synthetic biology, cancer screening, and 3D spatial analysis.
- Regulatory and Reimbursement: Navigating the complex landscape of genomics regulations and funding.
- Data and Informatics: Leveraging data to enhance genomic insights and inform decision-making.
- Consumer Genomics: Exploring the intersection of genomics and consumer health.
